article thumbnail

Study shines a light on representation in clinical research

Drug Discovery World

GSK’s retrospective study looked at clinical trial demographic data from 495 GSK and ViiV clinical trials involving US-based participants from the period 2002 to 2019. The post Study shines a light on representation in clinical research appeared first on Drug Discovery World (DDW).

article thumbnail

It’s About Time: FDA’s Proposed Rule to Amend Prior Notice Regulations

FDA Law Blog: Biosimilars

Food and Drug Administration (FDA) issued a proposed rule that would amend its prior notice regulations to add new information requirements and deadlines. The requirement for prior notice originates in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act). By Sophia R.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The regulatory round-up: Eight key FDA decisions

Drug Discovery World

Read more: ADC potential “standard of care” for some breast cancer patients NTLA-2002, Intellia Therapeutics The FDA cleared Intellia Therapeutics’ Investigational New Drug (IND) application for NTLA-2002 for the treatment of hereditary angioedema (HAE) in March.

FDA 130
article thumbnail

Analysis Chemical Thank You The 103 regulations the EPA is currently working on

Agency IQ

The 103 regulations the EPA is currently working on On July 5, 2024, the EPA published its Spring 2024 Unified Agenda, which reveals what regulations the agency is planning on releasing by the end of the year and beyond.

article thumbnail

Chinese Government Arrests GenScript and Legend Biotech Founder for Smuggling

The Pharma Data

Zhang’s arrest was for “the suspected offense of smuggling goods prohibited by the import and export regulations under the laws of the PRC,” according to a GenScript statement. Human genetic goods are tightly regulated by the Chinese government. Zhang had served as the chairman of board of directors of Legend Biotech since 2015.

article thumbnail

Can Europe become a major player in cell and gene therapy?

Drug Discovery World

It reveals that in 2002 the US spent just $2billion more than Europe on R&D, but by 2021 that figure increased to $20billion. Fortunately, the EFPIA report also offers a detailed list of recommendations and the hope that with a proactive approach to nurturing life sciences, this trend can be reversed. . The current situation .

Therapies 245
article thumbnail

Analysis Chemical Thank You EPA issues white paper exploring the adoption of structured content and digital pesticide labels

Agency IQ

Both labels would provide the framework for the consistent placement and order of the regulated portions of pesticide label information, with the digital label organizing the contents as data. The paper elaborates on the benefits of SLs for regulators, users, the regulated community, and the public. and internationally.